ClinicalTrials.Veeva

Menu

Use of Compressed Sensing in Breast MRI (COMPRIM)

I

Institut de Cancérologie de Lorraine

Status

Completed

Conditions

Breast Cancer

Treatments

Other: 3.0 Tesla in Magnetic Resonance Imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT02826369
2015-A00581-48

Details and patient eligibility

About

Breast MRI is increasingly important in breast screening imaging. It is currently based on dynamic sequences after contrast injection whose temporal resolution must be less than 90 seconds with dynamic acquisitions at different times.

These curves profiles are designed to differentiate benign from malignant lesions. Recently, Mann et al, (2014) showed that increasing the temporal resolution of dynamic acquisitions; lesion enhancement curves over time were more accurate than the curves usually performed.

It seems necessary to work on sequences having better temporal resolution without compromising however spatial resolution.

Enrollment

13 patients

Sex

Female

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient to benefit a MRI in the assessment for a breast carcinoma
  • Age >18 years old
  • Assessment on 3.0 Tesla in Magnetic Resonance Imaging
  • ECOG performance status ≤ 3
  • Ability to provide an informed written consent form

Exclusion criteria

  • Age < 18 years old
  • Claustrophobia
  • Contraindication to the injection of gadolinium contrast medium
  • Contraindication to MRI
  • Persons deprived of liberty or under supervision

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

13 participants in 1 patient group

3.0 Tesla in Magnetic Resonance Imaging
Experimental group
Treatment:
Other: 3.0 Tesla in Magnetic Resonance Imaging

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems